Halladay Benjamin — SEC insider filings

SEC reporting owner CIK 1953943. 19 insider filings on record with FilingPulse; latest filed 2026-10-06.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2022-12-12 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Esperion Therapeutics, Inc. (ESPR)Chief Financial Officer17—11 legs · 45,628 sh · $119,55314
ACHIEVE LIFE SCIENCES, INC. (ACHV)Chief Financial Officer2——2

Insider filings — Halladay Benjamin

FiledFormIssuerReported transactionsSource
2026-10-063ACHIEVE LIFE SCIENCES, INC. (ACHV)Holdings only — no transactions reportedEDGAR
2026-10-064ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2026-07-134Esperion Therapeutics, Inc. (ESPR)Disposition to issuer (D): 705,410 · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 213,000 (derivative) · Disposition to issuer (D): 221,270 (derivative)EDGAR
2026-06-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 10,773 @ $3.15EDGAR
2026-03-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 6,424 @ $2.71EDGAR
2026-03-164Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 247,430 @ $0 · Grant/award (A): 221,270 (derivative) @ $0EDGAR
2025-12-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 7,337 @ $3.67EDGAR
2025-09-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 7,046 @ $2.81EDGAR
2025-07-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 11 @ $1.11EDGAR
2025-06-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 7,229 @ $1.15EDGAR
2025-04-214Esperion Therapeutics, Inc. (ESPR)Sale (S): 8 @ $0.96EDGAR
2025-03-194Esperion Therapeutics, Inc. (ESPR)Sale (S): 3,535 @ $1.48EDGAR
2025-03-174Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 238,000 @ $0 · Grant/award (A): 213,000 (derivative) @ $0EDGAR
2025-02-204Esperion Therapeutics, Inc. (ESPR)Sale (S): 11 @ $1.86EDGAR
2025-01-214Esperion Therapeutics, Inc. (ESPR)Sale (S): 9 @ $2.27EDGAR
2024-12-184Esperion Therapeutics, Inc. (ESPR)Sale (S): 3,245 @ $2.42EDGAR
2024-03-154Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 170,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-03-154Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 9,200 @ $0 · Grant/award (A): 39,000 (derivative) @ $0EDGAR
2022-12-124Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 44,000 @ $0 · Grant/award (A): 66,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1953943 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs